To the full analysis
Braskem stock: growth
BAKBraskem reported $12.34B in revenue for fiscal 2025, down 10.4% on the prior year, up 3.4% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
9.2%
per year from 2006 to 2025, per share 4.7%
Earnings (Annual rate)
no data
Free cash flow (Annual rate)
no data
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2006 | |
|---|---|---|---|
| Revenue | 3.4% | 3.9% | 9.2% |
| Revenue per share | 3.4% | 3.9% | 4.7% |
| Earnings | no data | no data | no data |
| Earnings per share | no data | no data | no data |
| Free cash flow | no data | no data | no data |
| Free cash flow per share | no data | no data | no data |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2006 | $2.31B | $17.99M | −$97.27M |
| 2007 | $3.15B | $97.48M | $181.47M |
| 2008 | $3.2B | −$443.68M | $213.11M |
| 2009 | $2.71B | $163.3M | $92.19M |
| 2010 | $4.54B | $337.43M | $180.58M |
| 2011 | $5.91B | −$93.49M | $91.43M |
| 2012 | $6.32B | −$130.17M | −$42.15M |
| 2013 | $7.29B | $90.74M | −$574.05M |
| 2014 | $8.2B | $153.83M | −$274.2M |
| 2015 | $8.42B | $559.08M | $720.71M |
| 2016 | $8.49B | −$73.26M | $333.16M |
| 2017 | $8.77B | $726.91M | $33.55M |
| 2018 | $10.33B | $510.36M | $1.17B |
| 2019 | $9.32B | −$452.38M | −$74.28M |
| 2020 | $10.42B | −$1.19B | $629.03M |
| 2021 | $18.8B | $2.49B | $2.02B |
| 2022 | $17.18B | −$59.82M | $730.65M |
| 2023 | $12.56B | −$815.22M | −$1.21B |
| 2024 | $13.78B | −$2.02B | −$236.07M |
| 2025 | $12.34B | −$1.72B | −$1.27B |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = R$5.6169)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 30 Apr 2023)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.